Citation Impact
Citing Papers
Cancer-Associated Fibroblasts Expressing CXCL14 Rely upon NOS1-Derived Nitric Oxide Signaling for Their Tumor-Supporting Properties
2014
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Breast cancer
2019 Standout
Macrophages orchestrate breast cancer early dissemination and metastasis
2017
Clinical implications and utility of field cancerization
2007
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
2004
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
2012
HER‐2 pulsed dendritic cell vaccine can eliminate HER‐2 expression and impact ductal carcinoma in situ
2012
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Breast cancer
2016 Standout
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy
2017
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
2008 Standout
Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses
2011
Wnt signaling in cancer
2016 Standout
Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade
2017
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Head and neck cancer
2008 Standout
Cyclooxygenase-2 Up-regulates CCR7 via EP2/EP4 Receptor Signaling Pathways to Enhance Lymphatic Invasion of Breast Cancer Cells*
2008
Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002
2013
Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
2012
The biology and function of fibroblasts in cancer
2016 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
2005 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
The molecular biology of head and neck cancer
2010 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Robust enumeration of cell subsets from tissue expression profiles
2015 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Eicosanoids and cancer
2010 Standout
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells
2008 StandoutNobel
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
2010
Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV)
2018
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
2012
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
2013
An “elite hacker”
2012
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
2018
RASSF tumor suppressor gene family: Biological functions and regulation
2014
Breast cancer metastasis: markers and models
2005 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and genetics
2004
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Exosomes
2019 Standout
Nanomaterials for In Vivo Imaging
2017
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
2010
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
2013 Science
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis
2014
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Immune targeting in breast cancer.
2015
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
2015
Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro
2016
Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast Cancer
2007
Gene expression profiles of human breast cancer progression
2003
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy
2007
Works of Fredrik Wärnberg being referenced
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness
2001
Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis
2014
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
2010
Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
2013
Ductal Carcinoma in Situ of the Breast: a New Phenotype Classification System and its Relation to Prognosis
2002
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
2010
Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: Analysis of loss of heterozygosity
2005
Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer
2007
Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo
2006
The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies
2016
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort
2009
Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
2001
Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based Study
2012
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
2011
Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial
2014
Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples
2007